Christopher J Coughlin Karuna Therapeutics, Inc. (KRTX) insider trading activity

Christopher J Coughlin is of Karuna Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Mar 18, 2024, when has been sold 990 shares (Common Stock) at a price of $330.0 per share, resulting in proceeds of $326,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

CHRISTOPHER J COUGHLIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 18 2024	SELL Sale (or disposition) back to the issuer	$326,700 $330.0 p/Share	990 Reduced 100.0%	0 Common Stock
Jun 20 2023	BUY Grant, award, or other acquisition	-	990 Added 50.0%	990 Common Stock

Also insider at

CNC

CENTENE CORP Healthcare

Director

PBH

Prestige Consumer Healthcare Inc. Healthcare

Director

ALXN

ALEXION PHARMACEUTICALS, INC.

Director

CJC